Can oestrogenic activity in air contribute to the overall body burden of endocrine disruptors?

Cytotoxicity Endocrine disrupting chemicals In vitro assay MELN cells Particulate matter Risk assessment

Journal

Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 04 04 2023
revised: 12 07 2023
accepted: 14 07 2023
medline: 13 9 2023
pubmed: 18 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

Endocrine disruptors (EDCs) are emerging contaminants that are harmful to health. Human exposure occurs mainly through ingestion or dermal contact, but inhalation could be an additional exposure route; therefore, this study was conducted to evaluate the oestrogenic activity of airborne particulate matter (PM). Outdoor PM was collected for a year in five Italian sites and extracted with organic solvents (four seasonal extracts/site). The oestrogenic activity was assessed using a gene reporter assay (MELN), and the risk to human health through inhalation was quantified using the results. Moreover, extracts were analysed to assess cytotoxicity (WST-1 and LDH assays) on human bronchial cells (BEAS-2B). The extracts induced a significant cytotoxicity and oestrogenic activity. Oestrogenic activity showed a seasonal trend and was correlated with concentrations of benzo(a)pyrene and toxic equivalency factor. Although a low inhalation cancer risk was found, this study confirmed that oestrogenic activity in air could contribute to overall health risks due to EDC exposure.

Identifiants

pubmed: 37459960
pii: S1382-6689(23)00174-6
doi: 10.1016/j.etap.2023.104232
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Particulate Matter 0
Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104232

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marta Gea (M)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy. Electronic address: marta.gea@unito.it.

Manuela Macrì (M)

Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy.

Daniele Marangon (D)

Regional Agency for Environmental Protection of Piedmont (ARPA Piemonte), Grugliasco, TO, Italy.

Francesco Antonio Pitasi (FA)

Regional Agency for Environmental Protection of Piedmont (ARPA Piemonte), Grugliasco, TO, Italy.

Marco Fontana (M)

Regional Agency for Environmental Protection of Piedmont (ARPA Piemonte), Grugliasco, TO, Italy.

Sara Bonetta (S)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy.

Tiziana Schilirò (T)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH